Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization

Journal of Cell Science

Volumn 116, Issue 19, 2003, Pages 3917-3925

  Kurki, Sari ^a   Latonen, Leena ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

APL; DNA damage; Mdm2; Nucleolus; p53; PML; PML nuclear bodies

Indexed keywords

ARSENIC TRIOXIDE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEIN; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS INCLUSION BODY; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; REACTION ANALYSIS; STRESS; ULTRAVIOLET RADIATION;

ANIMALS; ARSENICALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; NUCLEAR MATRIX; NUCLEAR PROTEINS; OXIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 0142106346     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00714     Document Type: Article

References (58)

1. Ascoli, C. A. and Maul, G. G. (1991). Identification of a novel nuclear domain. J. Cell Biol. 112, 785-795.
2. Ashcroft, M. and Vousden, K. H. (1999). Regulation of p53 stability. Oncogene 18, 7637-7643.
3. Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicei, P. G. and Dejean, A. (2002). Deconstructing PML-induced premature senescence. EMBO J. 13, 3358-3369.
4. Blattner, C., Hay, T., Meek, D. W. and Lane, D. P. (2002). Hypophosphorylation of Mdm2 augments p53 stability. Mol. Cell. Biol. 22, 6170-6182.
5. Carbone, R., Pearson, M., Minucci, S. and Pelicci, P. G. (2002). PML NBs associate with the hMre 11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 21, 1633-1640.
6. de Thé, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990). The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558-561.
7. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Cohen, S., Marchetti, A., Del Sal, G. et al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4, 11-19.
8. Duprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., de Thé, H., Hay, R. T. and Freemont, P. S. (1999). SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112, 381-393.
9. Dyck, J. A., Maul, G. G., Miller, W. H., Jr, Chen, J. D., Kakizuka, A. and Evans, R. M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
10. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. and Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581-6591.
11. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
12. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. and Weissman, A. M. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8955.
13. Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C. and Lowe, S. W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14, 2015-2027.
14. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Sternsdorf, T., Jensen, K., Pandolfi, P. P., Will, H., Schneider, C. and del Sal, G. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185-6195.
15. Fuchsová, B., Novak, P., Kafkova, J. and Hozak, P, (2002). Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. J. Cell Biol. 158, 463-473.
16. Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M. and del Sal, G. (1999). Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 15, 6462-6471.
17. Grande, M. A., van der Kraan, I., van Steensel, B., Schul, W., de Thé, H., van der Voort, H. T., de Jong, L. and van Driel, R. (1996). PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell. Biochem. 63, 280-291.
18. Granick, D. (1975). Nucleolar necklaces in chick embryo fibroblast cells. II. Microscope observations of the effect of adenosine analogues on nucleolar necklace formation. J. Cell Biol. 65, 418-427.
19. Guiochon-Mantel, A., Savouret, J. F., Quignon, F., Delabre, K., Milgrom, E. and de Thé, H. (1995). Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9, 1791-1803.
20. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Go, W. and Pandolfi, P. P. (2000). The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2, 730-736.
21. Honda, R., Tanaka, H. and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
22. Honda, R. and Yasuda, H. (2000). Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473-1476.
23. Hoogstraten, D., Nigg, A. L., Heath, H., Mullenders, L. H., van Driel, R., Hoeijmakers, J. H., Vermeulen, W. and Houtsmüller, A. B. (2002). Rapid switching of TFIIH between RNA polymerase I and II transcription and DNA repair in vivo. Mol. Cell. 10, 1163-1174.
24. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E. and Yao, T. P. (2002). MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236-6245.
25. Jensen, K., Shiels, C. and Freemont, P.S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233.
26. Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Siloh, Y. and Shkedy, D. (1999). Rapid ATM-dependent phosphorylation of Mdm2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 14973-14977.
27. Kießlich, A., von Mikecz, A. and Hemmerich, P. (2002). Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J. Struct. Biol. 140, 167-179.
28. Klibanov, S. A., O'Hagan, H. M. and Ljungman, M. (2001). Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. J. Cell Sci. 114, 1867-1873.
29. Kwek, S. S., Derry, J., Tyner, A. L., Shen, Z. and Gudkov, A. V. (2001). Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20, 2587-2599.
30. 3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
31. Langley, E., Pearson, M., Faretta, M., Bauer, U. M., Frye, R. A., Minucci, S., Pelicci, P. G. and Kouzarides, T. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383-2396.
32. Latonen, L., Taya, Y. and Laiho, M. (2001). UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20, 6784-6793.
33. Latonen, L., Kurki, S., Pitkänen, K. and Laiho, M. (2003). p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. Cell Signal. 15, 95-102.
34. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J. and Go, W. (2002a). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653.
35. Li, M., Luo, J., Brooks, C. L. and Gu, W. (2002b). Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277, 50607-50611.
36. Ljungman, M., Zhang, F., Chen, F., Rainbow, A. J. and McKay, B. C. (1999). Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18, 583-592.
37. Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G. and Vousden, K. H. (2000). Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol. 2, 179-181.
38. Lombard, D. and Guarente, L. (2000). Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res. 60, 2331-2334.
39. Mattsson, K., Pokrovskaja, K., Kiss, C., Klein, G. and Szekely, L. (2001). Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc. Natl. Acad. Sci. USA 98, 1012-1017.
40. Melnick, A. and Licht, J. D. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
41. Miller, W. H., Jr, Schipper, H. M., Lee, J. S., Singer, J. and Waxman, S. (2002). Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903.
42. Montes de Oca Luna, R., Wagner, D. S. and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
43. Mu, Z.-M., Chin, K.-V., Liu, J.-H., Lozano, G. and Chang, K.-S. (1994). PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867.
44. Müller, S., Matunis, M. J. and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70.
45. Müller, S., Hoege, C., Pyrowolakis, G. and Jentsch, S. (2001). SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell. Biol. 2, 202-210.
46. Nefkens, I., Negorev, D. G., Ishov, A. M., Michaelsson, J. S., Yeh, E. T., Tanguay, R. M., Muller, W. E. and Maul, G. G. (2003). Heat shock and Cd(2+) exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J. Cell Sci. 116, 513-524.
47. Negorev, D. and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
48. Pause, S. L., Masson, C., Heliot, L., Chassery, J. M., Junera, H. R. and Hernandez-Verdun, D. (1999). 3-D organization of ribosomal transcription units after DRB inhibition of RNA polymerase II transcription. J. Cell Sci. 112, 2145-2154.
49. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P. and Pelicci, P. G. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
50. Pearson, M. and Pelicci, P. G. (2001). PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20, 7250-7256.
51. Quignon, F., de Bels, F., Koken, M., Feunteun, J., Ameisen, J. C. and de Thé, H. (1998). PML induces a novel caspase-independent death process. Nat. Genet. 20, 259-265.
52. Regad, T. and Chelbi-Alix, M. K. (2001). Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286.
53. Rodriguez, M. S., Desterro, J. M., Lain, S., Midgley, C. A., Lane, D. P. and Hay, R. (1999). SUMO-1 modification activates the transcriptional response of p53. EMBO J. 15, 6455-6461.
54. Seker, H., Rubbi, C., Linke, S. P., Bowman, E. D., Garfield, S., Hansen, L., Borden, K. L. B., Milner, J. and Harris, C. C. (2003). UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML. Oncogene 22, 1620-1628.
55. Weber, J. D., Taylor, L. J., Roussel, M., Sherr, C. J. and Bar-Sagi, D. (1999). Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1, 20-26.
56. Weber, J. D., Kuo, M.-L., Bothner, B., DiGiammarino, E. L., Kriwacki, R. W., Roussel, M. F. and Sherr, C. J. (2000). Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20, 2517-2528.
57. Zhong, S., Delva, L., Rachez, C., Cenciarelli, C., Gandini, D., Zhang, H., Kalantry, S., Freedman, L. P. and Pandolfi, P. P. (1999). A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat. Genet. 23, 287-295.
58. Zhong, S., Salomoni, P. and Pandolfi, P. P. (2000). The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90.